Can zinc oxide be used to treat a groin rash in an incontinent patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Zinc Oxide for Groin Rash in Incontinent Patients

Yes, zinc oxide should be used to treat and prevent groin rash (incontinence-associated dermatitis) in incontinent patients—it is specifically recommended in multiple clinical guidelines and FDA-approved for this indication. 1, 2

Direct Evidence Supporting Use

Zinc oxide is explicitly recommended by the 2024 AUA/SUFU Overactive Bladder Guidelines as an incontinence management strategy, specifically listing "barrier creams" among products to manage urinary incontinence and mitigate leaking's impact on quality of life 1. The FDA label for zinc oxide directly states it "helps treat and prevent diaper rash" and "protects chafed skin due to diaper rash - helps protect skin from wetness" 2—the same pathophysiology as incontinence-associated dermatitis in adults.

Guideline-Based Application Protocol

Multiple ESPEN guidelines (2020,2022) on enteral nutrition provide specific protocols for zinc oxide use in skin protection from bodily fluids, which directly translates to incontinence care:

  • Apply zinc oxide-based skin protectants (barrier film, paste, or cream) to surrounding skin when leakage of bodily fluids occurs 3, 4
  • Use as a powdered absorbing agent or barrier cream to minimize skin breakdown 3, 4
  • Combine with foam dressings rather than gauze (foam lifts drainage away from skin, whereas gauze traps moisture) 3, 5, 3

The 2011 Gastroenterology guidelines from the Society of Interventional Radiology and AGA Institute similarly recommend that "stoma adhesive powder or zinc oxide can be applied to the site to prevent local skin irritation" from gastric content leakage 5.

Clinical Effectiveness Evidence

A 2026 prospective cohort study of 164 institutionalized older patients with incontinence found zinc oxide ointments had a 27.8% incidence of IAD versus 32.9% for non-irritant barrier films—no statistically significant difference in effectiveness (p=0.479) 6. A 2024 pilot study demonstrated that zinc oxide products followed by petroleum jelly can prevent and decrease IAD severity while improving skin surface pH to mild acidity 7.

Application Strategy for Incontinent Patients

Based on the converging guideline evidence:

  1. Clean the groin area with water and mild soap (not harsh soaps) after each incontinence episode, especially with fecal contamination 8, 9
  2. Dry thoroughly before application
  3. Apply zinc oxide cream/ointment liberally to all at-risk skin areas (20% zinc oxide concentration per FDA formulation) 2
  4. Reapply after each cleansing following incontinence episodes
  5. Consider petroleum jelly over zinc oxide for enhanced barrier protection 7

Important Caveats

  • Treat underlying fungal infections if present with topical antifungals, as local fungal infections may be associated with persistent skin breakdown 3, 4
  • Address incontinence management concurrently—proper use of incontinence containment materials is essential 9
  • Monitor for contact dermatitis, though zinc oxide has excellent safety profile with no adverse events reported in clinical studies 6, 7
  • The 2009 Stroke Guidelines emphasize that urinary incontinence increases dermatitis incidence, making prevention critical for rehabilitation outcomes and preventing nursing home placement 8

Zinc oxide is both guideline-recommended and FDA-approved for exactly this indication—there is no reason to withhold it from incontinent patients with groin rash.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.